(160) - Evaluation of Seralutinib Treatment Effect Across Four Risk Tools in the TORREY Study in Pulmonary Arterial Hypertension (PAH).
- Resource Type
- Article
- Authors
- Benza, R.L.; Osterhout, R.; Hoffman, S.; Zamanian, R.T.; Hemnes, A.R.; Channick, R.N.; Chin, K.M.; Frantz, R.P.; Ghofrani, A.; Howard, L.S.; McLaughlin, V.V.; Vachiery, J.; Zisman, L.S.; Cravets, M.; Bruey, J.; Roscigno, R.F.; Mottola, D.; Aranda, R.; Sitbon, O.
- Source
- Journal of Heart & Lung Transplantation. 2024 Supplement, Vol. 43 Issue 4, pS86-S87. 2p.
- Subject
- *PULMONARY arterial hypertension
*TREATMENT effectiveness
- Language
- ISSN
- 1053-2498